Shares of Senores Prescription drugs Ltd skyrocketed 8% on 4 March after the corporate introduced that they’d acquired 14 Abbreviated New Drug Functions (ANDAs) from Dr. Reddy’s Laboratories by means of its subsidiary Senores Prescription drugs, Inc.
In its regulatory submitting, the corporate mentioned, “Senores Prescription drugs Restricted (SPL), by means of its wholly-owned subsidiary Senores Prescription drugs, Inc., USA (SPI), has signed agreements right now to accumulate a basket of 14 Abbreviated New Drug Functions (‘ANDAs’) from Dr. Reddy’s Laboratories and its relevant associates.”
The acquired portfolio consists of 13 Abbreviated New Drug Functions (ANDAs) already authorised by the U.S. Meals and Drug Administration (USFDA) and one ANDA presently awaiting approval.
In response to IQVIA, the market potential for these acquired ANDAs within the U.S. is roughly $421 million (MAT December 2024), whereas knowledge from Symphony estimates it at $1.13 billion (MAT September 2024).
The acquisition shall be financed utilizing proceeds from the Preliminary Public Providing (IPO) raised by SPL, aligning with the targets outlined within the Crimson Herring Prospectus.
Senores Prescription drugs is a worldwide, research-focused pharmaceutical firm specializing within the improvement and manufacturing of a broad vary of pharmaceutical merchandise for the U.S., Canada, and different regulated and rising markets throughout a number of therapeutic areas and dosage kinds.
The corporate’s present portfolio consists of 27 ANDAs and 21 CMO/CDMO business merchandise authorised for distribution within the U.S. Moreover, Senores is actively concerned in creating and producing advanced generics licensed by international regulatory authorities, supplying generic medicine to over 40 nations.
Senores’ manufacturing facility in Chhatral is authorised by regulatory companies from greater than 10 nations, with over 260 registered merchandise and 530 product functions for rising markets. The corporate additionally manufactures important care injectables and Lively Pharmaceutical Elements (APIs).
At 3:30 pm, the shares of Senora Pharma closed 6.03% larger at Rs 562.50 on NSE.
Ask the analyst & get prompt reply about Senores Prescription drugs Ltd.
The way forward for investing is right here!
Unicorn Alerts leverages superior AI expertise to give you highly effective market predictions and actionable inventory scans. Obtain the app right nowand 10x your buying and selling & investing journey!
